期刊文献+

化学物质生殖毒性替代方法的研究现状

Current status and developments of alternative methods in reproductive and developmental toxicity
下载PDF
导出
摘要 科技发展和人类进步,促进3R理论发展,即减少、替代和优化试验动物的使用。因此,众多努力用于毒理学替代方法的研究。生殖和发育毒性检测中使用的动物数量最多,但因哺乳动物生殖周期的复杂性,生殖发育毒性替代方法的研究进展缓慢。胚胎干细胞、微团检测和全胚胎培养试验,以及非洲蟾蜍胚胎试验,可作为发育毒性的筛检方法。利用人生殖细胞体外模型进行生殖毒性研究是一个挑战。跨领域技术、传感器技术、(Q)SARs及各种组学技术的迅速发展,都将使生殖发育毒性替代方法的研究得到新的发展和突破。 Scientific and technological development and the advance of human civilization are promoting three Rs concept, i. e, the replacement, reduction or refinement of animal tests. By far the largest proportion of animals in safety testing will be needed for testing of reproductive and developmental toxicity. Hence, the efforts in developing alternative tests are in particular directed to this area. The complexity of the reproductive cycle in mammals might be the main reason why success is limited up to now. The embryonic stem cell test, the micromass test, the rat postimplantation whole embryo cuhure test and the frog embryo teratogenesis assay-xenopus can be used for screening of chemicals for possible developmental toxicity. Use of human reproductive cells in vitro model in reproductive toxicity study is a challenge. The study of alternatives in reproductive developmental toxicity will have the new development and breakthroughs, because development of cross cutting technologies, sensor technologies, (Q) SARs and pattern-based methods (e. g. toxicogenomics, proteomics and metabonomics).
出处 《中国药理学通报》 CAS CSCD 北大核心 2009年第3期415-417,共3页 Chinese Pharmacological Bulletin
关键词 生殖毒性 替代方法 reproductive toxicity alternative methods
  • 相关文献

参考文献15

  • 1Russell W M S, Burch R L. The Principles of Human Experimental Techniques [ M ]. London : Methuen, 1959. Available : http ://altweb. jhsph, edu/publications/humane exp/het-toc.
  • 2OECD (2007c) Draft guidance document on mammalian reproductive toxicity testing and assessment. OECD Environment, Health and Safety Publications [ R ]. Series on Testing and Assessment No. 43, Paris.
  • 3Hofer T, Gerner I, Gundert-Remy U, et al. Animal testing and alternative approaches for the human healthrisk assessment under the proposed new European chemicals regulation [ J ]. Arch Toxicol, 2004,78:549 - 64.
  • 4Pellizzer C, Bremer S, Hartung T. Developmental toxicity testing from animals towards embryonic stem cells [ J ]. ALTEX, 2005,22 : 47 - 57.
  • 5Fort D J, Propst T L, Stover E L, et al. Assessing the predictive validity of Frog Embryo Teratogenesis Assay : Xenopus ( FETAX ) [ J 1. Teratog Carcinog Mutagen,2000,20 ( 2 ) : 87 - 98.
  • 6Whitlow S, Burgin H, Clemann N. The embryonic stem cell test for the early selection of pharmaceutical compounds [ J ]. ALTEX, 2007,24:3 - 8.
  • 7Kumi-Diaka J,Nguyen V,Butler A. Cytotoxic potential of the phytochemical genistein isoflavone (4',5',7-trihydroxyisoflavone) and certain environmental chemical compounds on testicular cells [ J ]. Biol Cell, 1999,91,515 - 23.
  • 8Audus K L. Controlling drug delivery across the placenta[ J]. Eur J Pharm Sci, 1999,8 ( 3 ) : 161 - 5.
  • 9Verwei M, van Burgsteden J A, Krul C A, et al. Prediction of in vivo embryotoxic effect levels with a combination of in vitro studies and PBPK modelling[ J]. Toxicol Lett ,2006,165:79 -87.
  • 10Hareng L, Pelizzer S, Schwarz M, Hartung T. The integrated project Reprotect :a novel approach to reproductive hazard assessment [ J ]. Reprod Toxicol,2005 ,20 :441 - 52.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部